Biomarin Pharmaceutical Inc

Ownership Transactions Reported by 26 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	3	-17K	100%	$68.19	-$1.16M
Net	-3	-17K	-100%		-$1.16M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jean Jacques Bienaime	Director	$55.6M			May 20, 2024
Henry J. Fuchs	President, Worldwide R&D	$15.7M			Sep 13, 2024
Alexander Hardy	Chief Executive Officer, Director	$12.2M			Mar 14, 2025
Richard A. Meier	Director	$8.03M			May 20, 2025
Elaine J. Heron	Director	$7.47M			Jun 3, 2024
Brian Mueller	EVP, Chief Financial Officer	$6.93M			Mar 14, 2025
George Eric Davis	EVP, Chief Legal Officer	$5.76M			Mar 14, 2025
Charles Greg Guyer	EVP, Chief Technical Officer	$5.61M	-$852K	-13.2%	Mar 14, 2025
Jeffrey Robert Ajer	EVP, Chief Commercial Officer	$5.54M			May 2, 2024
E. Pyott David	Director	$3.83M			May 21, 2024
V. Bryan Lawlis	Director	$3.19M			May 23, 2023
Robert J. Hombach	Director	$2.64M			May 20, 2025
Dennis Slamon	Director	$2.62M			Mar 18, 2024
Willard H. Dere	Director	$2.45M			May 20, 2025
Gregory R. Friberg	EVP, Chief R&D Officer	$2.36M			Sep 30, 2025
Elizabeth M. Anderson	Director	$2.17M			May 20, 2025
Cristin Hubbard	EVP, Chief Commercial Officer	$1.83M	-$17.7K	-0.96%	May 20, 2025
Maykin Ho	Director	$1.76M			May 20, 2025
Andrea Acosta	GVP, Chief Accounting Officer	$1.75M			Apr 30, 2021
Mark J. Alles	Director	$1.45M			May 23, 2023
Barbara W. Bodem	Director	$854K			May 20, 2025
Mark Enyedy	Director	$853K			May 20, 2025
Athena Countouriotis	Director	$853K			May 20, 2025
Erin Burkhart	GVP, Chief Accounting Officer	$841K	-$290K	-25.7%	May 19, 2025
Timothy P. Walbert	Director	$642K			May 20, 2025
Ian T. Clark	Director	$434K			Aug 1, 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.